Diagnostic performance of urinary adipsin as a screening biomarker for pre‐eclampsia
Urinary adipsin showed high sensitivity, specificity, and predictive value in diagnosing pre-eclampsia. This highlights its potential as a non-invasive biomarker for pre-eclampsia screening in low-resource settings. Routine urinary adipsin assay and blood pressure monitoring could enhance early detection strategies and improve maternal and perinatal outcomes.
Authors
- Peter Paul Mwinsanga Dapare (ORCID: https://orcid.org/0000-0002-1209-0221)
- Bernard Gyan
- Bismark Opoku Mensah (ORCID: https://orcid.org/0000-0001-9787-6575)
- Linda Ahenkorah Fondjo (ORCID: https://orcid.org/0000-0003-0252-3190)
- Ernestina Anim
Institutions
- All Nations University (GH)
- Kwame Nkrumah University of Science and Technology (GH)
- Kintampo Health Research Centre (GH)
- University of Worcester (GB)
- University for Development Studies (GH)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1002/ijgo.70619
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00